Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 163

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience

Open access
Moningi, Shalini, Dholakia, Avani S., Raman, Siva P., Blackford, Amanda, Cameron, John L., Le, Dung T., De Jesus-Acosta, Ana M. C., Hacker-Prietz, Amy, Rosati, Lauren M., Assadi, Ryan K., Dipasquale, Shirl, Pawlik, Timothy M., Zheng, Lei, Weiss, Matthew J., Laheru, Daniel A., Wolfgang, Christopher L., Herman, Joseph M. · 2015 · Annals of Surgical Oncology

Abstract

BackgroundStereotactic body radiation therapy (SBRT) is a promising option for patients with pancreatic cancer (PCA); however, limited data support its efficacy. This study reviews our institutional experience of SBRT in the treatment of locally advanced (LAPC) and borderline resectable (BRPC) PCA.MethodsCharts of all PCA patients receiving SBRT at our institution from 2010 to 2014 were reviewed. Most patients received pre-SBRT chemotherapy. Primary endpoints included overall survival (OS) and local progression-free survival (LPFS). Patients received a total dose of 25–33 Gy in five fractions.ResultsA total of 88 patients were included in the analysis, 74 with LAPC and 14 with BRPC. The median age at diagnosis was 67.2 years, and median follow-up from date of diagnosis for LAPC and BRPC patients was 14.5 and 10.3 months, respectively. Median OS from date of diagnosis was 18.4 months (LAPC, 18.4 mo; BRPC, 14.4 mo) and median PFS was 9.8 months (95 % CI 8.0–12.3). Acute toxicity was minimal with only three patients (3.4 %) experiencing acute grade ≥3 toxicity. Late grade ≥2 gastrointestinal toxicity was seen in five patients (5.7 %). Of the 19 patients (21.6 %) who underwent surgery, 79 % were LAPC patients and 84 % had margin-negative resections.ConclusionsChemotherapy followed by SBRT in patients with LAPC and BRPC resulted in minimal acute and late toxicity. A large proportion of patients underwent surgical resection despite limited radiographic response to therapy. Further refinements in the integration of chemotherapy, SBRT, and surgery might offer additional advancements toward optimizing patient outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1245/s10434-014-4274-5

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 163

Metadata

Authors
Moningi, S., Dholakia, A. S., Raman, S. P., Blackford, A., Cameron, J. L., Le, D. T., De Jesus-Acosta, A. M. C., Hacker-Prietz, A., Rosati, L. M., Assadi, R. K., Dipasquale, S., Pawlik, T. M., Zheng, L., Weiss, M. J., Laheru, D. A., Wolfgang, C. L., & Herman, J. M.
Venue
Annals of Surgical Oncology
Published
2015-01-07
Volume
22
Issue
7
Pages
2352-2358
ISSN
  • 1068-9265 (ISSN-L)
  • 1534-4681
OpenAlex
W2091193950
Cited by
163
References
1
FWCI
8.97
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience. https://app.cochat.ai/papers/10.1245/s10434-014-4274-5
The paper
Moningi, S., Dholakia, A. S., Raman, S. P., Blackford, A., Cameron, J. L., Le, D. T., De Jesus-Acosta, A. M. C., Hacker-Prietz, A., Rosati, L. M., Assadi, R. K., Dipasquale, S., Pawlik, T. M., Zheng, L., Weiss, M. J., Laheru, D. A., Wolfgang, C. L., & Herman, J. M. (2015). The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-014-4274-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.